12- SLE

Cards (41)

  • Autoimmune disorder

    Characterized by exacerbations and remissions, leading to inflammation and tissue damage involving multiple organs systems
  • Women account for 90% of cases, more frequently African American
  • Etiology
    • Genetic
    • Environmental
    • Drug-induced
  • Genetic factors

    • HLA-DR2, HLA-DR3, HLA-B8
    • Low complement gene C1q C2 C4
  • Environmental factors

    • Exposure to EBV
    • UV light exposure
    • Hormonal factors: estrogen
  • Drug-induced factors

    • hydralazine, isoniazid, procainamide, penicillamine
  • Most common initial findings

    • Malar rash
    • Joint pain
    • Fatigue
  • Constitutional symptoms

    • Fatigue
    • Malaise
    • Fever
    • Weight loss
  • Multiple organ involvement leads to many manifestations
  • Diagnosis of SLE
    Based on the presence of at least 4 of 11 manifestations
  • Skin manifestations

    • Malar rash
    • Discoid rash
    • Photosensitivity
    • Oral or nasopharyngeal ulcers
  • Joint manifestations

    • Arthritis (inflammatory and symmetrical but not erosive)
    • Arthralgia
  • Chest manifestations

    • Serositis: pleuritis or pericarditis (chest pain +/- pericardial/pleural effusion)
  • Renal manifestations

    • Glomerulonephritis
    • Proteinuria
    • Hematuria
    • Azotemia
    • ESRD
  • Neurological manifestations

    • Psychosis
    • Seizures
    • Stroke
    • Headaches
  • Hematological manifestations

    • Hemolytic anemia
    • Leukopenia
    • Lymphopenia
    • Thrombocytopenia
  • Anemia of chronic disease is a more common presentation, but it is not part of the diagnostic criteria
  • Immunological manifestations

    • Positive ANA
    • Positive anti-dsDNA or anti-Sm
    • False +ve test for syphilis
  • Libman-Sacks endocarditis

    • Sterile vegetations
  • Myocarditis
    May lead to arrhythmias
  • Accelerated atherosclerosis
  • Thrombosis (both arterial & venous)

    Must rule out pulmonary embolism in any SLE pt with acute SOB
  • Other manifestations of SLE (but not part of diagnostic criteria)

    • Libman-Sacks endocarditis (sterile vegetations)
    • Myocarditis (may à arrhythmias)
    • Accelerated atherosclerosis
    • Thrombosis (both arterial & venous) à must rule out pulmonary embolism in any SLE pt with acute SOB
    • Pneumonitis (may lead to fibrosis)
    • Cranial nerve lesions, polyneuropathy, aseptic meningitis
    • Mesenteric vasculitis, vasculitic lesions of fingertips and nail folds
    • Raynaud's phenomenon (vasospasm of small vessels when exposed to cold)
    • Antiphospholipid syndrome
    • Aseptic necrosis of the hip/knee
    • Alopecia, urticaria, purpura
    • Photophobia, retinal lesions (cotton-wool spots), blindness
  • Most common cause of death in young pts is infection, and in old patients is accelerated atherosclerosis à MI
  • Positive ANA screening tests

    • Very sensitive but not specific
  • Anti-dsDNA (60%) and Anti-Sm (30%) Ab

    Presence is diagnostic, specific
  • Antibodies found in 15% to 35%

    • Ro (SS-A)
    • La (SS-B)
  • Ro (SS-A) and La (SS-B)

    • More often found in Sjogren syndrome
    • Anti-Ro in pregnant mother's blood increases risk of neonatal SLE and heart block, check baby ECG
  • Ribosomal P

    Marker for cerebral lupus
  • Antihistone Abs

    Marker for drug-induced lupus
  • Complement levels

    • Decreased C3 and C4
  • Inflammatory markers
    • High ESR
  • Markers of disease activity (acute flare)

    • Drop in complement level C3 C4
    • Rise in anti-dsDNA levels
  • Increased ESR/CRP is NOT a marker of disease activity. If higher inflammatory markers than baseline, look for infection
  • Treatment
    1. Avoid sun exposure
    2. Control of cardiovascular risk factors
  • NSAIDs
    For arthralgia and less severe symptoms
  • Acute flare treatment
    High-dose boluses of steroids
  • Long-term therapy

    • Antimalarial agents such as hydroxychloroquine (Plaquenil)
    • Best long-term therapy for mild chronic disease limited to skin & joints
    • Annual eye examination is needed because of retinal toxicity
  • Belimumab
    1. lymphocyte stimulator monoclonal Ab. Inhibits B-cell activating factor. Controls progression of SLE.
  • Lupus nephritis treatment

    1. Steroids + cyclophosphamide
    2. Need kidney biopsy
    3. Care of nephrologist